Oramed Pharmaceuticals Inc (ORMP)
2.35
+0.01
(+0.43%)
USD |
NASDAQ |
May 03, 16:00
2.355
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Free Cash Flow: -10.55M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.55M |
| September 30, 2023 | -17.50M |
| June 30, 2023 | -19.13M |
| March 31, 2023 | -24.99M |
| December 31, 2022 | -28.41M |
| September 30, 2022 | -26.95M |
| June 30, 2022 | -30.75M |
| March 31, 2022 | -27.88M |
| November 30, 2021 | -21.99M |
| August 31, 2021 | -21.56M |
| May 31, 2021 | -17.92M |
| February 28, 2021 | -15.64M |
| November 30, 2020 | -15.99M |
| August 31, 2020 | -12.52M |
| May 31, 2020 | -13.25M |
| February 29, 2020 | -13.56M |
| November 30, 2019 | -11.82M |
| August 31, 2019 | -12.96M |
| May 31, 2019 | -14.34M |
| February 28, 2019 | -14.48M |
| November 30, 2018 | -16.07M |
| August 31, 2018 | -14.66M |
| May 31, 2018 | -12.06M |
| February 28, 2018 | -10.62M |
| November 30, 2017 | -10.06M |
| Date | Value |
|---|---|
| August 31, 2017 | -5.838M |
| May 31, 2017 | 3.015M |
| February 28, 2017 | 3.142M |
| November 30, 2016 | 8.393M |
| August 31, 2016 | 4.646M |
| May 31, 2016 | -3.185M |
| February 29, 2016 | -1.867M |
| November 30, 2015 | -5.795M |
| August 31, 2015 | -4.947M |
| May 31, 2015 | -4.723M |
| February 28, 2015 | -4.848M |
| November 30, 2014 | -4.73M |
| August 31, 2014 | -4.082M |
| May 31, 2014 | -3.560M |
| February 28, 2014 | -3.575M |
| November 30, 2013 | -3.362M |
| August 31, 2013 | -3.402M |
| May 31, 2013 | -3.461M |
| February 28, 2013 | -3.291M |
| November 30, 2012 | -2.612M |
| August 31, 2012 | -2.303M |
| May 31, 2012 | -2.384M |
| February 29, 2012 | -2.089M |
| November 30, 2011 | -1.694M |
| August 31, 2011 | -1.708M |
Free Cash Flow Range, Past 5 Years
-30.75M
Minimum
Jun 2022
-10.55M
Maximum
Dec 2023
-18.83M
Average
-17.50M
Median
Sep 2023
Free Cash Flow Benchmarks
| Inogen Inc | -30.24M |
| Petros Pharmaceuticals Inc | -7.626M |
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.418M |
| Cash from Investing (Quarterly) | 30.00M |
| Cash from Financing (Quarterly) | -25.00M |
| Free Cash Flow Per Share (Quarterly) | -0.0342 |
| Free Cash Flow Yield | -11.07% |